Shanghai Labway Clinical Laboratory Co Ltd (301060) — Capital Reinvestment Ratio
Shanghai Labway Clinical Laboratory Co Ltd (301060) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥135.78 Million) in capital expenditures (CN¥13.41 Million). See 301060 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Labway Clinical Laboratory Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Shanghai Labway Clinical Laboratory Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Shanghai Labway Clinical Laboratory Co L (301060) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥268.85 Million | CN¥58.49 Million | ▼ -38.6% |
| 2024 | 0.35x | CN¥216.31 Million | CN¥76.62 Million | ▼ -51.4% |
| 2023 | 0.73x | CN¥546.99 Million | CN¥398.89 Million | ▼ -73.3% |
| 2022 | 2.73x | CN¥84.17 Million | CN¥230.08 Million | ▲ +413.9% |
| 2021 | 0.53x | CN¥223.51 Million | CN¥118.88 Million | ▲ +100.4% |
| 2020 | 0.27x | CN¥167.87 Million | CN¥44.55 Million | ▼ -52.6% |
| 2019 | 0.56x | CN¥70.60 Million | CN¥39.51 Million | ▲ +41.0% |
| 2018 | 0.40x | CN¥184.79 Million | CN¥73.34 Million | ▼ -89.6% |
| 2016 | 3.80x | CN¥27.14 Million | CN¥103.24 Million | ▲ +614.4% |
| 2015 | 0.53x | CN¥79.70 Million | CN¥42.45 Million | ▼ -94.6% |
| 2013 | 9.90x | CN¥1.63 Million | CN¥16.13 Million | — |